HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Amyloidosis and aging].

Abstract
Amyloidosis is a heterogeneous group of extracellular protein deposition diseases. Age-related amyloidosis may be systemic or localized. The systemic forms include associated-myeloma AL amyloidosis and senile systemic amyloidosis which is the only clear-cut systemic form related to age and derived from normal transthyretin. In localized amyloidosis, the fibril protein precursors are synthesized in the tissue involved by the amyloid. In most cases, localized age-related amyloidosis does not appear to cause clinical disease with the exception of amyloid associated with Alzeihmer's disease and type 2 diabetes mellitus. The significance of aortic amyloidosis, amyloidosis of seminal vesicles, amyloid of the endocrine glands, and articular amyloidosis remains unknown.
AuthorsNagi Mimassi, Pierre Youinou, Yvon-Louis Pennec
JournalAnnales de medecine interne (Ann Med Interne (Paris)) Vol. 153 Issue 6 Pg. 383-8 (Oct 2002) ISSN: 0003-410X [Print] France
Vernacular TitleAmylose et vieillissement.
PMID12486387 (Publication Type: English Abstract, Journal Article, Review)
Chemical References
  • Apolipoproteins E
  • Glycosaminoglycans
  • Serum Amyloid P-Component
Topics
  • Aged
  • Aged, 80 and over
  • Aging
  • Amyloidosis (classification, diagnosis)
  • Apolipoproteins E (analysis)
  • Cerebral Amyloid Angiopathy (classification, diagnosis)
  • Cerebral Amyloid Angiopathy, Familial (diagnosis)
  • Glycosaminoglycans (analysis)
  • Humans
  • Serum Amyloid P-Component (analysis)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: